Maternal Folate Polymorphisms and the Etiology of Human Nondisjunction
AUTOR(ES)
Hassold, Terry J.
FONTE
The American Society of Human Genetics
RESUMO
Attempts to identify genetic contributors to human meiotic nondisjunction have met with little, if any, success. Thus, recent reports linking Down syndrome to maternal polymorphisms at either of two folate metabolism enzymes, methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR), have generated considerable interest. In the present report, we asked whether variation at MTHFR (677C→T) or MTRR (66A→G) might be associated with human trisomies other than trisomy 21. We analyzed maternal polymorphisms at MTHFR and MTRR in 93 cases of sex-chromosome trisomy, 44 cases of trisomy 18, and 158 cases of autosomal trisomies 2, 7, 10, 13, 14, 15, 16, 18, or 22, and compared the distributions of genotypes to those of control populations. We observed a significant increase in the MTHFR polymorphism in mothers of trisomy 18 conceptuses but were unable to identify any other significant associations. Overall, our observations suggest that, at least for the sex chromosomes and for a combined set of autosomal trisomies, polymorphisms in the folate pathway are not a significant contributor to human meiotic nondisjunction.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1235315Documentos Relacionados
- Maternal age and origin of non-disjunction in trisomy 21.
- Taking folate in pregnancy and risk of maternal breast cancer
- Taking folate in pregnancy and risk of maternal breast cancer: Authors' reply
- Folate metabolism gene polymorphisms may influence lung cancer prognosis
- Can the genetic polymorphisms of the folate metabolism have an influence in the polycystic ovary syndrome?